1. Home
  2. MDXH vs YHNA Comparison

MDXH vs YHNA Comparison

Compare MDXH & YHNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • YHNA
  • Stock Information
  • Founded
  • MDXH 2003
  • YHNA 2023
  • Country
  • MDXH Belgium
  • YHNA Hong Kong
  • Employees
  • MDXH N/A
  • YHNA N/A
  • Industry
  • MDXH
  • YHNA
  • Sector
  • MDXH
  • YHNA
  • Exchange
  • MDXH Nasdaq
  • YHNA Nasdaq
  • Market Cap
  • MDXH 93.1M
  • YHNA 79.9M
  • IPO Year
  • MDXH 2021
  • YHNA 2024
  • Fundamental
  • Price
  • MDXH $1.96
  • YHNA $10.07
  • Analyst Decision
  • MDXH Strong Buy
  • YHNA
  • Analyst Count
  • MDXH 2
  • YHNA 0
  • Target Price
  • MDXH $7.00
  • YHNA N/A
  • AVG Volume (30 Days)
  • MDXH 145.0K
  • YHNA 21.1K
  • Earning Date
  • MDXH 02-26-2025
  • YHNA 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • YHNA N/A
  • EPS Growth
  • MDXH N/A
  • YHNA N/A
  • EPS
  • MDXH N/A
  • YHNA N/A
  • Revenue
  • MDXH $84,708,000.00
  • YHNA N/A
  • Revenue This Year
  • MDXH $27.57
  • YHNA N/A
  • Revenue Next Year
  • MDXH $20.09
  • YHNA N/A
  • P/E Ratio
  • MDXH N/A
  • YHNA N/A
  • Revenue Growth
  • MDXH 33.01
  • YHNA N/A
  • 52 Week Low
  • MDXH $1.55
  • YHNA $10.00
  • 52 Week High
  • MDXH $4.44
  • YHNA $11.28
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 38.10
  • YHNA N/A
  • Support Level
  • MDXH $1.97
  • YHNA N/A
  • Resistance Level
  • MDXH $2.25
  • YHNA N/A
  • Average True Range (ATR)
  • MDXH 0.16
  • YHNA 0.00
  • MACD
  • MDXH -0.04
  • YHNA 0.00
  • Stochastic Oscillator
  • MDXH 0.00
  • YHNA 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About YHNA YHN Acquisition I Limited Ordinary Shares

YHN Acquisition I Ltd is a newly organized blank check company for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities.

Share on Social Networks: